Alkermes

NASDAQ: ALKS ↗$52.89 USD~$3B MCAP

alkermes — company profile generated 2026-07-09.

Company Info

Sector:Biotechnology

Headquarters:TBD

Founded:0

Alkermes' incoming CEO has a plan to outplay Lilly and Takeda (BioPharma Dive.)

Leadership Team

Careers & Job Openings

Multiple Departments

Various